Gökhan Batur
Plus aucun poste en cours
Profil
Gokhan Batur joined XGEN as Venture Partner in 2023.
He has 19 years of healthcare industry experience.
Formerly he was the CEO at Polyphor, a late-stage publicly listed Swiss biotech focused to oncology and anti-infectives.
Prior, he assumed various management roles at MSD, lastly serving as Executive Director, Global Brand Leader, Antibiotics, responsible for leading the entire Merck antibiotics portfolio managing multiple in-line and pipeline products and sales of ~2B$.
In addition to his role at XGEN, Gokhan is a board member at APIM Therapeutics and corporate advisor to several biotechs in Europe and the US.
Postes actifs de Gökhan Batur
| Sociétés | Poste | Début |
|---|---|---|
APIM Therapeutics AS
 APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | Director/Board Member | 01/08/2022 |
Xgen Venture Sgr SpA
 Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | Private Equity Investor | 01/01/2023 |
Anciens postes connus de Gökhan Batur
| Sociétés | Poste | Fin |
|---|---|---|
| SPEXIS AG | Chief Executive Officer | 31/03/2022 |
| SPEXIS AG | Chief Executive Officer | 30/12/2021 |
Formation de Gökhan Batur
| Bogazici University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SPEXIS AG | Health Technology |
| Entreprise privées | 2 |
|---|---|
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | Health Technology |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | Finance |
